-
Found on FT.com.
Posted: September 3rd, 2010, 6:31pm CEST
Roche confirmed speculation about significant job cuts to tailor its spending to tougher market conditions, but said it would not give details until later this year...
-
Found on FT.com.
Posted: September 3rd, 2010, 3:20am CEST
The private equity owner of Sterigenics, a US medical device sterilisation group, has hired JPMorgan to run an auction of the company that it hopes will raise about $800m...
-
Found on FT.com.
Posted: September 3rd, 2010, 12:36am CEST
Tests in Ireland abandoned after three of 12 people receiving the treatment suffer seizures and are admitted to hospital. The Irish Medicines Board has launched an investigation into the incident...
-
Found on FT.com.
Posted: September 2nd, 2010, 9:00pm CEST
Scientists have cured malaria in mice with a single dose of a new drug, the journal Science reports...
-
Found on FT.com.
Posted: August 31st, 2010, 8:33pm CEST
The troubled US biotech believes it is undervalued by the French drugmaker – but it cannot afford to be too choosy...
-
Found on FT.com.
Posted: August 31st, 2010, 8:27pm CEST
Genzyme's removal of some of its takeover defences – including a poison pill and staggered directors' appointments – makes the US biotech group more vulnerable to a hostile bid...
-
Found on FT.com.
Posted: August 30th, 2010, 7:14pm CEST
Genzyme rejected a takeover offer from Sanofi-Aventis, calling the French pharmaceutical group's $69 a share bid 'opportunistic' and 'unrealistic'...
-
Found on FT.com.
Posted: August 29th, 2010, 10:39pm CEST
Sanofi-Aventis steps up its pursuit of Genzyme, outlining publicly its interest in a deal as the French pharmaceuticals group inches closer to making a hostile offer for the US biotech...
-
Found on FT.com.
Posted: August 28th, 2010, 12:20am CEST
The troubled care home group declines to enter further negotiations with TowerBrook amid an indicative takeover offer by the UK-based private equity company...
-
Found on FT.com.
Posted: August 25th, 2010, 7:34pm CEST
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells...
-
Found on FT.com.
Posted: August 25th, 2010, 7:34pm CEST
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells...
-
Found on FT.com.
Posted: August 23rd, 2010, 9:08pm CEST
Chris Viehbacher needs to reinvigorate the French group's research and development pipeline for the production of new innovative drugs to replace existing ones going off patent...
-
Found on FT.com.
Posted: August 23rd, 2010, 9:08pm CEST
Chris Viehbacher needs to reinvigorate the French group's research and development pipeline for the production of new innovative drugs to replace existing ones going off patent...
-
Found on FT.com.
Posted: August 22nd, 2010, 11:48pm CEST
Documents made public during litigation on the pharmaceutical group's antipsychotic drug Seroquel highlight apparent efforts by the group to communicate favourable data selectively to boost prescriptions...
-
Found on FT.com.
Posted: August 22nd, 2010, 11:48pm CEST
Documents made public during litigation on the pharmaceutical group's antipsychotic drug Seroquel highlight apparent efforts by the group to communicate favourable data selectively to boost prescriptions...
-
Found on FT.com.
Posted: August 22nd, 2010, 9:14pm CEST
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines...
-
Found on FT.com.
Posted: August 22nd, 2010, 9:14pm CEST
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines...
-
Found on FT.com.
Posted: August 22nd, 2010, 6:43pm CEST
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan...
-
Found on FT.com.
Posted: August 22nd, 2010, 6:43pm CEST
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan...
-
Found on FT.com.
Posted: August 20th, 2010, 10:16pm CEST
Western companies have been tempted by strong sales of their older medicines, as well as a willingness by the Chinese authorities to authorise western prices for innovative drugs...
